These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30825298)

  • 41. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
    Rolle CE; Carrio R; Malek TR
    Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.
    Ramakrishnan R; Assudani D; Nagaraj S; Hunter T; Cho HI; Antonia S; Altiok S; Celis E; Gabrilovich DI
    J Clin Invest; 2010 Apr; 120(4):1111-24. PubMed ID: 20234093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.
    Celus W; Oliveira AI; Rivis S; Van Acker HH; Landeloos E; Serneels J; Cafarello ST; Van Herck Y; Mastrantonio R; Köhler A; Garg AD; Flamand V; Tamagnone L; Marine JC; Di Matteo M; Costa BM; Bechter O; Mazzone M
    Cancer Immunol Res; 2022 Jan; 10(1):126-141. PubMed ID: 34815265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.
    Weigelin B; Bolaños E; Teijeira A; Martinez-Forero I; Labiano S; Azpilikueta A; Morales-Kastresana A; Quetglas JI; Wagena E; Sánchez-Paulete AR; Chen L; Friedl P; Melero I
    Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7551-6. PubMed ID: 26034288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of Melan-A/MART-1-specific CD8+ cytotoxic T lymphocytes from human naive precursors: helper effect requirement for efficient primary cytotoxic T lymphocyte induction in vitro.
    Ostankovitch M; Le Gal FA; Connan F; Chassin D; Choppin J; Guillet JG
    Int J Cancer; 1997 Sep; 72(6):987-94. PubMed ID: 9378563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of Tumor Antigen-Specific Cytotoxic T Lymphocytes from Pluripotent Stem Cells.
    Chen X; Lei F; Wang L; Xiong X; Song J
    Methods Mol Biol; 2019; 1884():43-55. PubMed ID: 30465194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mouse CD8
    Li Z; Wu Y; Wang C; Zhang M
    Cancer Immunol Immunother; 2019 Aug; 68(8):1303-1315. PubMed ID: 31278476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. OCT4&SOX2-specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem-like cells in vitro and treating drug-resistant lung cancer mice in vivo.
    Zhang X; Hu F; Li C; Zheng X; Zhang B; Wang H; Tao G; Xu J; Zhang Y; Han B
    J Cell Physiol; 2019 May; 234(5):6758-6768. PubMed ID: 30382588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Killing activity of cytotoxic T lymphocytes stimulated by dendritic cell vaccine loaded with autologous cervical cancer antigen].
    Zhou CJ; Ma W; Zhou JD; Zhao YX; Xie HQ
    Ai Zheng; 2006 Feb; 25(2):143-7. PubMed ID: 16480575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.
    Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X
    Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8+ cytotoxic T lymphocytes against breast cancer cells in vitro.
    Cui H; Zhang W; Hu W; Liu K; Wang T; Ma N; Liu X; Liu Y; Jiang Y
    PLoS One; 2013; 8(5):e63055. PubMed ID: 23650543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T; Oka M; Takashima M; Ueno T; Yamamoto K; Yahara N; Yoshino S; Hazama S
    Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
    Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic T cells swarm by homotypic chemokine signalling.
    Galeano Niño JL; Pageon SV; Tay SS; Colakoglu F; Kempe D; Hywood J; Mazalo JK; Cremasco J; Govendir MA; Dagley LF; Hsu K; Rizzetto S; Zieba J; Rice G; Prior V; O'Neill GM; Williams RJ; Nisbet DR; Kramer B; Webb AI; Luciani F; Read MN; Biro M
    Elife; 2020 Oct; 9():. PubMed ID: 33046212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.
    Chen X; Kunda PE; Lin J; Zhou M; Huang J; Zhang H; Liu T
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):675-684. PubMed ID: 29372378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
    Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
    Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial translation is required for sustained killing by cytotoxic T cells.
    Lisci M; Barton PR; Randzavola LO; Ma CY; Marchingo JM; Cantrell DA; Paupe V; Prudent J; Stinchcombe JC; Griffiths GM
    Science; 2021 Oct; 374(6565):eabe9977. PubMed ID: 34648346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.
    Lee CH; Kakinuma T; Wang J; Zhang H; Palmer DC; Restifo NP; Hwang ST
    Mol Cancer Ther; 2006 Oct; 5(10):2592-9. PubMed ID: 17041104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.